Publication

Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology

Explore how model-based tumor growth inhibition metrics can support earlier Go/No-Go decisions and pivotal trial…

CertaraAugust 28, 2026

Webinar

The Road to First-in-Human: Model-Informed Decisions from Discovery to First Dose

Danielle PillsburyAugust 28, 2026

Video

See an AI assistant run a PK analysis

Watch an AI assistant run a full population PK analysis using the NLME MCP Server,…

CertaraAugust 28, 2026

Video

Watch TFL Studio kill the copy-paste era

Watch how TFL Studio helps PK and PD scientists build tables, figures, and listings up…

CertaraAugust 28, 2026

Video

See AI PK Reports in action

Watch how AI PK Reports uses generative AI to turn tables, figures, and listings into…

CertaraAugust 28, 2026

Video

From blank page to working model, fast

Watch how Model Designer brings cloud based pharmacometric modeling to your browser, with guided wizards,…

CertaraAugust 28, 2026

Blog

Why pharmacometrics automation is the foundation of modern PK/PD

Pharmacometrics automation is reshaping PK/PD workflows. Explore five principles driving AI, cloud infrastructure, and model…

Sebastian KuechenmeisterAugust 28, 2026

Webinar

How to Choose Your First-in-Human Dose Approach

CertaraAugust 17, 2026

Blog

A model-informed approach to radioligand therapy dosing under Project Optimus

Explore how targeted radionuclide therapy dosing uses QSP, biologically effective dose (BED), and exposure-response modeling…

Hunter Stephens, PhDAugust 13, 2026

Webinar

Exploratory data analysis of a drug-biomarker-efficacy PD model

CertaraAugust 12, 2026

Modeling and Simulation – PK/PD

Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology

The Road to First-in-Human: Model-Informed Decisions from Discovery to First Dose

See an AI assistant run a PK analysis

Watch TFL Studio kill the copy-paste era

See AI PK Reports in action

From blank page to working model, fast

Why pharmacometrics automation is the foundation of modern PK/PD

How to Choose Your First-in-Human Dose Approach

A model-informed approach to radioligand therapy dosing under Project Optimus

Exploratory data analysis of a drug-biomarker-efficacy PD model

Newsletter sign up

Quick links

Solutions

Contact